Factors like cold, dry weather, an immune system response, oily skin, and using alcohol-based lotions also contribute. A history of other skin disorders, including rosacea, psoriasis, and acne, may ...
Complete enrollment in its DMT310 Phase 3 STAR-1 clinical trial in moderate-to-severe acne. Dermata expects to complete enrollment in the STAR-1 study by the end of 2024 and plans to announce topline ...